All News

The US facility in Rockville is expected to accelerate the company’s commercial-scale manufacturing timelines of gavo-cel

The CDMO will provide cell line development, process development, drug substance and drug product manufacturing for Pionyr’s monoclonal antibody candidate

The former Rohner's manufacturing assets will enable omega-3 heavyweight to manufacture difficult, multi-step pharmaceutical intermediates and APIs

Pharma company will provide fill and finish manufacturing capacity at its Barnard Castle facility as early as the beginning of May 2021

Innovation in the design and development of large volume drug delivery devices can solve the challenge of accommodating the increasing trend towards patient self-administration and home care while at the same time ensuring that drugs that require intra...

Some seaborne deliveries are being rerouted or switched to air transportation as efforts to re-float stricken Ever Given container vessel move into fourth day

New site includes warehouse maagement system which packaging firm claims will increase picking accuracy and efficiency

While research and development (R&D) in the pharma sector has traditionally been largely constrained to in-house activity, companies are now much more open to the idea of outsourcing their innovation to remain competitive amid spiralling costs of drug ...

Company will use extension of Schedule I licence to start development of psychedelics-based pipeline to treat mental health disorders

The company will triple its capacity and workforce at its North Carolina site to increase its global capabilities and reach

A quarterly series of blog posts about responsible supply chain management from the PSCI Chair, Manjit Singh

Partnering with one of northern Europe’s oldest academic universities, Lund University in Sweden, Pharmapack has launched this three-part podcast series, delivering the latest insights on medication packaging innovation and the gathering momentum...

The CDMO's Zydis technology will help the Canadian biotech to develop fast-acting, shorter-duration formulations of its potential therapy for treatment-resistant psychiatric disorders

CDMO subsidiary Fujifilm Diosynth Biotechnologies will operate the site which is expected to be operational in 2025

Pharma’s uptake of continuous manufacturing is slowly gaining traction as the technology does hold some key advantages over traditional batch manufacturing, such as the potential to realise cost savings and the promise of lower yield loss.

EU/UK trade deal fell way short of UK’s initial expectations for medicinal products ahead of negotiations, says Peter Gough at NSF International

Multinational makes ‘difficult decision’ to halt presence in Chinese biosimilars market five years after $350 million investment

Despite COVID-related challenges and supply chain issues, the CDMO's $240 million new facility is on target to open next year

AI is helping pharma find the drug candidates with the greatest chance of success, according to experts who say therapeutic efficacy and cost reduction are the key dynamics

The move ensures the service provider has the capacity to meet the needs of an evolving clinical market

US-headquartered company Kindeva seals deal for an R&D facility at Loughborough’s life sciences hub

Excipients are a crucial component of the pharmaceutical product formulation, and the industry is constantly having to adapt to changes in demand and technology innovations

Adaptive clinical trials have accelerated COVID-19 vaccine development and could make drug R&D more efficient but running such studies is complex and challenging and sponsors need to prepare, say experts

Regulators stress temporary halt is precautionary measure and that there is currently no evidence linking the shot to adverse events

Tremendous growth opportunities exist for auto-injectors as their value is increasingly being recognised across several therapy areas, experts have told a recent CPHI webinar, sponsored by Stevanato Group.

What are APIs? As the name suggests, Active Pharmaceutical Ingredients (APIs) are the heart of any dosage form, whether they are oral, injectable or inhaled, and are absolutely essential to the development of a formulated product.

The purchase will allow the company to add nine new customers to its growing CDMO business and 27 manufacturing suites

In this special roundtable podcast exploring potential opportunities in a post-vaccinated world, we are joined by a panel of three world class experts – Bikash Chatterjee, CEO of Pharmatech Associates; Parrish Galliher, Managing Director, Bi...

Biologic products advance through clinical development with a higher success rate than traditional small molecules, this new analysis of clinical development success from Informa Pharma Intelligence, the Biotechnology Industry Organization and the...

The enhancements will include installing the lever-operated multi-dose inhaler device used in Hikma’s generic Advair product, which the FDA recently approved

During the next 12 months, demand for early-stage contract projects could quickly exceed supply

PsiVac has generated compelling efficacy data in killing a broad range of tumour cells, including head and neck, bladder, liver, pancreatic and ovarian

In this podcast interview with Fabien Du Fraisse and Deepu Joseph at Quanticate, we delve into the trend of decentralising clinical trials 

Funding from BARDA helps the company to adapt and make available a number of existing manufacturing facilities for the production of SARS-CoV-2 vaccines and medicines

The addition further strengthens WuXi's cell and gene therapy service offerings for global customers and will be Wuxi ATU's first facility in Europe

Watch this recent webinar which looks at how pharma is partnering with digital tech companies in order to find market-based solutions to current issues and take advantage of the larger volumes of data now available

This transaction complements Pharmaron’s recent acquisition of Absorption Systems in the US for building an integrated cell and gene therapy services platform

Need clarity on determining your QA from your QbD and your cGMPs? You’re not alone! In our new Pharma Explained series from CPHI, we bring you clear cut definitions from industry experts on a myriad of Pharma Terms, delivered in bitesize video presenta...

The ongoing global pandemic and growing complexity mean digital technologies are fast becoming the only effective way of managing drug supply chains and logistics

The company acquires a pDNA CDMO and launches pDNA development and manufacturing services at its Rockville, Maryland facility

Need clarity on determining your QA from your QbD and your cGMPs? You’re not alone! In our new Pharma Explained series from CPHI, we bring you clear cut definitions from industry experts on a myriad of Pharma Terms, delivered in bitesize video present...

The new site will be equipped to enable quick ramp-up of capacity for clinical and commercial cell therapy products

Digitalisation is finally coming to pharma with more drug manufacturers using industry 4.0 tech to monitor, model and control production processes.

The CDMO will manufacture recently FDA-approved Lupkynis as a softgel dosage form at its St Petersburg, Florida, facility

The manufacturing agreement includes process development for scale-up and technology transfer with the goal of supplying Phase II and III clinical studies

Biotech will manufacture shots with partner SII for equitable vaccine distribution programme, COVAX

API manufacturer says acquisition is next step of investment strategy to closely align API supply to customer needs in an unpredictable world

Which were the products that drew the most interest in the CPHI directory in January? We analyse search data from the CPHI directory…

CDMO says increased customer demand for clinical API supply has outstripped its cGMP manufacturing capacity

Online analysis finds vaccine misinformation continues to thrive despite recent approvals and inoculation programmes

The CDMO doubles its capacity to take on new development projects

In this episode we delve into the issue of Pharma 4.0 and what steps the industry is taking to transition pharma manufacturing to a much more digitalised model.

The expanded and refined first-in-human services have been designed to meet the early-stage molecule development of small biopharma players

The company seeks to actively accelerate US manufacturing for medicines at risk of shortage, including those for COVID-19 pandemic response

The company's additional production capacities are scheduled to go into operation in May 2021

Firms plan to invest in capacity expansion at the CDMO’s manufacturing site in Dessau to boost European domestic vaccine supply

Partnering with one of northern Europe’s oldest universities, Lund University in Sweden, Pharmapack is launching this three-part podcast series, delivering the latest insights on medication packaging innovation and the gathering momentum towards ...

Need clarity on determining your QA from your QbD and your cGMPs? You’re not alone! In our new Pharma Explained series from CPHI, we bring you clear cut definitions from industry experts on a myriad of Pharma Terms, delivered in bitesize video presenta...

The acquisition will extend the 12-month drug development timeline savings already delivered by Quotient’s flagship platform Translational Pharmaceutics

The agreement allows the CDMO to "stay on the forefront of emerging indications and cell types"

The CRO predicts investment communities will come to the rescue of small and medium companies looking to advance their candidates

The CMO has designed the new service to alleviate manufacturing challenges associated with positive controls and nucleic acid templates

The acquisition will expand the CDMO's capabilities and capacity to serve European markets

By Yifei Chen and Yasemin Bettina Karanis, IQVIA

By Yifei Chen and Yasemin Bettina Karanis, IQVIA

The CPO's new division will offer a holistic blister packaging development service, complete with QA and non-destructive leak testing, encompassing material selection, tooling design, and 3D prototyping

Joint venture between Recipharm and Medspray could provide significant advantages for patients and the environment, companies say

How are changes in new treatments and disease areas – as well as the current pandemic crisis - affecting demand for APIs?

The company's £0.5 million investment in mass spectrometry support accelerates biologics development and approval

European Commission pressures pharma firm over reduced shipments amid criticism for slow vaccine rollout across block

The CDMO gears up for rapid deployment of its clinical-to-commercial manufacturing operations for its seventh collaboration to help deliver COVID-19 treatments

Acquisition will add Mesa's rapid PCR test for infectious diseases including COVID-19 to global CDMO's diagnostics offering

The donation from Ineos will create a new institute to tackle the "silent pandemic"

Even before the COVID-19 pandemic, the pharmaceutical manufacturing sector was adopting digital technology to save time, cut costs and increase efficiencies in the value chain.

If you’re looking for news, product information and market trends from leading pharma companies, the CPHI-Online.com Company Showcases are a great resource for buyers who want to stay up to date, browse product portfolios and find the right partn...

Manufacturing of active pharmaceutical ingredients has always been about innovating to cater for shifting demand patterns, but the recent coronavirus pandemic has raised further questions about whether the sector is doing enough to eke out efficiencies...

The collaboration aims to accelerate the development and commercialization of groundbreaking cell-based regenerative cures

Expanded global capacity addresses growing demand for cell and gene therapy

New report from Fitch Solutions points to greater consumer awareness of health insurance benefits in MENA region amid pandemic crisis and assesses individual countries' progress in vaccine procurement and rollout

AmpTec's differentiated PCR-based technology has shown to have advantages compared with other technologies for mRNA manufacturing

Which were the products that drew the most interest in the CPHI directory in December? We analyse search data from the CPHI directory…

Needle free systems offer compelling advantages for mass vaccination - could this be a potential platform for COVID19 vaccination programmes?

Increasing complexity of novel drugs and cost constraints have encouraged medicines administration to be shifted away from their traditional setting of a hospital or clinic to more cost-effective alternatives such as the patient’s own home. The a...

Manufacturing at Baxter's Halle/Westfalen, Germany facility will help increase commercial production and promote access in UK and European markets

The new facility will house up to 12 X 2000-L bioreactors and will be equipped to handle existing and new advances in manufacturing

The company hopes its newly built fill and finish facility will assume commercial manufacturing this year

The $40 million investment marks the company's third viral vector manufacturing site

The CDMO will use its gene and cell therapy commercial expertise to bring "remarkable innovation" to young eligible patients

Acquisition will extend the Chinese CDMO’s European footprint and will complement Leverkusen drug product site

CDMO will add two production suites for clinical and commercial supply and extend lab space to double analytical and process development capacity

The third in a quarterly series of blog posts about responsible supply chain management from the PSCI Chair, Caroline O'Brien

Newly formed generics business identifies the first five impacted plants as it seeks to reduce costs by $1 billion by the end of 2024

The company will be responsible for the formulation, filling, and packaging of Ad26.COV2-S at its new €30 million injectable products plant in Barcelona

Two new facilities in Germany will provide clinical supply and cold chain services to support growing demand

Through the acquisition, Lilly will establish a gene therapy program via Prevail's gain clinical-stage and preclinical neuroscience assets

With a value of more than $1,000 billion in 2019 and enjoying a 5% increase during that year, the global pharmaceutical sector is in good health. But it is also a moving universe, in which both the digital and design revolutions have changed the game o...

The expansion will enable the CDMO to widen the nature of inhaled drug development projects it can undertake for customers

Dutch CDMO will expand with two additional viral vector production lines to meet the increased demand

The CDMO will provide packaging, labeling and distribution services through its FastChain demand-led supply offering

World’s largest syringe maker gears up for increased demand across all product classes amid expected COVID-19 vaccine roll out

UK-based CDMO makes ‘significant investment’ as companies combine HPAPI small molecule expertise with antibody drug conjugate specialism

COVID-19 has been a major focus for drug regulators on both sides of the Atlantic in 2020. But efforts to help industry combat the pandemic did not appear to have had a major impact on review activities judging by the drugs approved so far this year

The €160 million investment will double the company's single-use bioreactor mammalian cell-culture capacity

The first-of-its-kind manufacturing service delivers tested sterile, non-GMP media designed for feasibility testing before scale-up, to support development of cell and gene therapies

Industry customers now have access to 24/7 real-time shipment visibility across the company's entire product portfolio

The Eyesight Health Market is emerging and related products are a booming business. With age, aging and the overuse of electronics in work and life, especially in 2020, people are spending more time on smartphones, tablets and e-readers because of the ...

At Dr. Reddy’s, we’re in the business of ensuring good health for both people and the planet. Our experts will share insights on our sustainability approach and on how it helps B2B customers support their sustainable supply chain performance while sour...

Discover all key features and benefits of plastic coating options offered by SGD Pharma

If you’re looking for news, product information and market trends from leading pharma companies, the CPHI-Online.com Company Showcases are a great resource for buyers who want to stay up to date, browse product portfolios and find the right partn...

Which were the products that drew the most interest in the CPHI directory in November?

The company will invest in dedicated early-phase development and cGMP manufacturing to help customers rapidly advance challenging molecules

Twelve pharma market trends we anticipate across 2021 for the drug development, manufacturing and outsourcing sectors.

AZD1222 is 90% effective, cheap to produce and easy to store, distribute and administer

The CDMO is already making certain investments to enable technology transfer and scale-up to commence imminently.

The partnership will focus on commercializing eight biosimilar medicines in China for the domestic market

Virtual Expo Connect to empower access for international pharma to the world’s largest pharma ingredients market

The agreement comes hot on the heels of FDA approval of Gavreto — Blueprint Medicines' new treatment for lung cancer

Junker, B., Lester, M., Brix, T., Wong, D., & Nuechterlein, J. (2006). A next generation, pilot-scale continuous sterilization system for fermentation media. Bioprocess And Biosystems Engineering, 28(6),